课题基金 / 基金详情

MESENCHYMAL CELL DIFFERENTIATION

MESENCHYMAL CELL DIFFERENTIATION
间充质细胞分化
批准号:
3876116
负责人:
GINETTE SERRERO
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

GINETTE SERRERO的其他基金

相似基金

相关文献

中文摘要
翻译
细胞的增殖、承诺和分化过程 间充质细胞将在细胞水平上使用 畸胎瘤来源的双潜能细胞系1246和胰岛素- 以1246细胞衍生的独立变异细胞系为模型 系统。1246细胞系具有以下属性:(1)它可以 分化为脂肪细胞或肌肉细胞;(2)它可以 在限定的培养液中增殖并进行脂肪分化 而其他成脂细胞系可以在特定的培养液中生长 但需要胎牛血清来分化;3)它的生长和 分化严格依赖于是否存在 胰岛素;4)其条件培养液可替代血清 刺激几种成脂细胞系的分化。 从1246个细胞中分离出一种不依赖胰岛素的变异细胞系 与世隔绝。这种已经失去分化能力的细胞系 在其培养基中产生一种脂肪分化抑制剂 有效地阻断几种成脂细胞系的分化和 大鼠和小鼠脂肪细胞的原代培养。实验是 建议对两者的表达进行表征、纯化和研究 两种细胞产生的脂肪分化调节剂的类型 台词。这项研究将是我们的长期目标的一部分 与要素表征有关的调查 控制生长、承诺和分化过程 间充质来源的细胞系并了解其 作用机制。
英文摘要
The processes of proliferation, commitment and differentiation of mesenchymal cells will be studied at the cellular level using the teratoma-derived, bipotential cell line 1246 and an insulin- independent variant cell line derived from 1246 cells as a model system. The 1246 cell line has the following properties; (1) it can differantiate either into adipocytes or into muscle cells; (2) it can proliferate and undergo adipose differentiation in defined medium whereas other adipogenic cell lines can grow in defined medium but require fetal calf serum to differentiate; 3) its growth and differentiation are stringently dependent on the presence of insulin; and 4) its conditioned medium is able to replace serum to stimulate the differentiation of several adipogenic cell lines. From 1246 cells, an insulin-independent variant cell line has been isolated. This cell line which has lost the ability to differentiate produces in its culture medium an adipose differentiation inhibitor active to block differentiation of several adipogenic cell lines and of primary cultures of rat and mouse adipocytes. Experiments are proposed to characterize, purify and study the expression of both types of adipose differentiation regulators produced by both cell lines. This study will be part of the long-term objective of our investigations related to the characterization of factors controlling growth, commitment and differentiation processes of mesenchymal-derived cell lines and to understand their mechanism of action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF NOVEL ANTICANCER AGENT TO POTENTIATE SENSITIVITY TO ANTI-ESTROGEN THERAPY
  • 批准号:
    8935272
  • 项目类别:
  • 资助金额:
    $147.86万
  • 财政年份:
    2014
  • 负责人:
    GINETTE SERRERO
  • 依托单位:
AUTOCRINE SECRETION IN TERATOMA VARIENTS
MESENCHYMAL CELL DIFFERENTIATION
FACTORS PRODUCED BY TERATOMA VARIANTS AND IN VIVO TUMORIGENICITY
国内基金
海外基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现